In the same year, Yoshida et al. reported nine cases of vulvar tumors with special immunohistochemical characteristics, including estrogen receptor positive and S100 protein and glial fibrillary acidic protein negative with simultaneously losing expression of INI1/SMARCB1, and named them MELTVR [2]. Here, SMARCB1 is linked to vulvar neoplasm.